COVID-19 Breaking News
-
Lonza to Manufacture AstraZeneca's COVID-19 Long-Acting Antibody Combination
Contract Pharma Staff || 10.30.20
cGMP manufacturing of the two long-acting antibodies to begin in H1 2021 at Lonza's Portsmouth, NH (USA) site.
-
Lilly, U.S. Govt. Enter Supply Pact for Bamlanivimab COVID-19 Treatment
Contract Pharma Staff || 10.28.20
Initial agreement is for 300,000 vials of the investigational neutralizing antibody with potential for purchase of an additional 650,000 vials.
-
Stevanato, Catalent Partner to Expedite Equipment Installation
Contract Pharma Staff || 10.27.20
Stevanato’s high-speed visual inspection machines will support biologic and vaccine programs at Catalent manufacturing sites in U.S. and Italy.
-
Gilead’s Remdesivir Wins FDA Approval to Treat COVID-19
Contract Pharma Staff || 10.23.20
Veklury is now the first and only approved COVID-19 treatment in the U.S.
-
LaunchWorks CDMO Approved to Provide Viral Transport Media
Contract Pharma Staff || 10.23.20
Added to FDA list of approved vendors for validating and distributing VTM, in accordance with COVID-19 EUA Transport Media Policy.
-
Moderna Completes Enrollment in Phase III COVID-19 Vax Study
Contract Pharma Staff || 10.22.20
COVE study designed in collaboration with the FDA and NIH to evaluate Americans at the highest risk of severe COVID-19 disease in 30,000 participants.
-
Roche, Atea Pharma to Develop Potential Oral COVID-19 Treatment
Contract Pharma Staff || 10.22.20
To develop, manufacture and distribute AT-527, Atea’s investigational oral direct-acting antiviral being studied to treat COVID-19.
-
India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines
S Harachand, Contributing Editor || 10.20.20
CMOs expand and ‘repurpose’ capacities.
-
Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
10.20.20
Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.
-
AstraZeneca, U.S. Govt. Enter $486M COVID-19 Antibody Agreement
Contract Pharma Staff || 10.16.20
Funding will be used for two Phase III trials and related development and manufacturing activities for the supply of AZD7442 doses in the U.S.
-
J&J Pauses All Trials Evaluating COVID-19 Vax Candidate
Contract Pharma Staff || 10.16.20
Temporarily pauses further dosing in all COVID-19 vaccine candidate trials to investigate an an unexplained illness.
-
Lilly Pauses ACTIV-3 Clinical Trial in Hospitalized COVID-19 Patients
Contract Pharma Staff || 10.16.20
ACTIV-3 study is evaluating the efficacy of Lilly’s neutralizing antibody in hospitalized COVID-19 patients, the most advanced stage of the disease.
-
Thermo Fisher to Expand Sterile Filling Capacity with New Facility in Singapore
10.15.20
Investment supports global health and preparedness in the Asia-Pacific region.
-
Contract Manufacturing and Pandemic Resilience
Angela Holley and Scott Cohon, WDPrx - Woodfield Pharmaceutical, LLC || 10.14.20
The Evolving Scope of Research, Product Development and Tech Transfer
-
RedHill Biopharma Ramps-Up Manufacturing of Opaganib
Contract Pharma Staff || 10.14.20
Collaborates with specialty manufacturers in Europe and Canada.
-
The Pandemic’s Become an Insurmountable Opportunity
Emil W. Ciurczak, Contributing Editor || 10.14.20
Every Cloud has a Silver Lining(?)
-
KindredBio Expands Manufacturing Agreement with Vaxart
Contract Pharma Staff || 10.13.20
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.
-
U.S. Govt. Selects LabVantage’s LIMS
Contract Pharma Staff || 10.13.20
Walter Reed Army Research Inst. will use LIMS to support the production of vaccines for COVID-19 and other diseases.
-
Fujifilm Diosynth to Manufacture Lilly COVID-19 Antibody
Contract Pharma Staff || 10.13.20
Commercial manufacturing of the antibody therapy is expected to commence in April 2021.
-
Mapi Pharma Commissions Facility to Support Supply of COVID-19 Vaccines
Contract Pharma Staff || 10.08.20
Makes available its production, cold-chain and storage capacities for the delivery of vaccines to Israel and the EU.
